Manchester Startup Imperagen Lands £5M to Speed Up Enzyme Innovation with Quantum AI

Manchester-based biotech firm Imperagen has raised £5 million in seed funding to make enzyme engineering faster and more reliable using quantum physics and artificial intelligence.

This latest round brings the company's total funding to £8.5 million and comes as demand grows for better enzymes in medicine and green manufacturing.

How Quantum AI Could Transform Everyday Products

Enzymes have helped humans make food and drinks for thousands of years, but modern uses now include creating drugs and breaking down waste.

Imperagen combines computer simulations based on quantum physics with custom AI models to test millions of possible enzyme changes without endless lab trials.

The approach uses robots to gather real data that trains the AI even better in a closed feedback loop.

This could one day allow smaller companies to develop enzymes for breaking down plastics, which would cut pollution in a big way.

CEO Guy Levy-Yurista, who took the role recently, brings strong experience in AI and life sciences to help turn the technology into commercial products.

The fresh money will go toward hiring more AI experts, expanding the lab, and building sales partnerships over the next two years.

Industry watchers expect such tools to make drug discovery quicker and lower the cost of sustainable alternatives to chemicals made from oil.

For regular people this means safer medicines, cleaner food production, and everyday items that are better for the planet without higher prices.

Overall the move shows how advanced computing is changing biology to solve real-world problems like climate change and health care access.